Deferred revenue Increase (Decrease) in Contract with Customer, Liability Award amount Revenue From Grants, Maximum Award Revenue From Grants, Maximum Award Document Type Document Type Outstanding, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] PPP, CARES Act Paycheck Protection Program, CARES Act [Member] Paycheck Protection Program, CARES Act Number of stock options granted (shares) Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Series A Preferred Series A Preferred Stock [Member] Related Party [Axis] Related Party [Axis] Income from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Consecutive trading days Class of Warrant or Right, Threshold Consecutive Trading Days Class of Warrant or Right, Threshold Consecutive Trading Days Equity Components [Axis] Equity Components [Axis] Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Minimum Minimum [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Receivables [Abstract] Accrued issuance costs for public offering Stock Issuance Costs Accrued and Amortized Stock Issuance Costs Accrued and Amortized Total fair value of assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Payments on note payable Repayments of Notes Payable Proceeds from warrants exercised for cash Proceeds from Warrant Exercises Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Statistical Measurement [Domain] Statistical Measurement [Domain] Liabilities and stockholders' equity Liabilities and Equity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Schedule of Fair Value Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Preferred Stock Preferred Stock [Member] Security Exchange Name Security Exchange Name FAIR VALUE OF FINANCIAL INSTRUMENTS Fair Value Disclosures [Text Block] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] Summary of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Equity-Based Compensation Share-based Payment Arrangement [Policy Text Block] Loss before other income (expense) Operating Income (Loss) Fair value of Flex Pharma outstanding options on the merger date Business Combination, Consideration Transferred, Fair Value of Outstanding Options Business Combination, Consideration Transferred, Fair Value of Outstanding Options Entity Registrant Name Entity Registrant Name Business Acquisition [Line Items] Business Acquisition [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and Contingencies Commitments and Contingencies Assets Assets [Abstract] Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Accounting Policies [Abstract] Accounting Policies [Abstract] Cash received in reverse acquisition Cash Acquired from Acquisition Weighted-Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Equity-based compensation expense Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Entity Address, State or Province Entity Address, State or Province Accounts payable Accounts Payable, Current Warrants exercised for cash (shares) Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Accumulated deficit Retained Earnings (Accumulated Deficit) Preferred shares converted to common shares Stock Issued During Period, Value, Conversion of Convertible Securities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Impairment of goodwill Goodwill, Impairment Loss Current funding available Revenue From Grants, Aggregate Amount Received, Current Funding Available Revenue From Grants, Aggregate Amount Received, Current Funding Available Class B Common Class B [Member] Award term Revenue From Grants, Award Term Revenue From Grants, Award Term Number of shares outstanding Outstanding, Beginning Balance (shares) Outstanding, Ending Balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Sale of Stock [Axis] Sale of Stock [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Weighted-average number of common shares outstanding — basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Equity, beginning balance (shares) Equity, ending balance (shares) Shares, Outstanding Preferred stock, $0.0001 par value; 10,000,000 shares authorized; 0 issued and outstanding Preferred Stock, Value, Issued Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Net loss per share (in dollars per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Income Taxes Income Tax, Policy [Policy Text Block] Goodwill Goodwill Wedbush Wedbush Securities Inc. [Member] Wedbush Securities Inc. Schedule of Variables used in Black-Scholes Model Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Total operating expenses Operating Expenses Document Transition Report Document Transition Report Exercisable (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Warrants outstanding (shares) Class of Warrant or Right, Outstanding Fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Principal amount Debt Instrument, Face Amount Distribution to stockholders Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Other prepaid and current assets Other Assets, Current Document Quarterly Report Document Quarterly Report Grant revenue Revenue from Contract with Customer, Excluding Assessed Tax Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Measurement Frequency [Domain] Measurement Frequency [Domain] Equity [Abstract] Equity [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Business Acquisition [Axis] Business Acquisition [Axis] Deferred revenue Contract with Customer, Liability, Current Stock options, contractual term Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Granted, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Prepaid expense financed by note payable Prepaid Expense Financed by Note Payable Prepaid Expense Financed by Note Payable Statement [Line Items] Statement [Line Items] Effect of reverse acquisition (shares) Stock Issued During Period, Shares, Acquisitions Class of Stock [Domain] Class of Stock [Domain] GRANTS RECEIVABLE Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Expected life (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Prepaid expense and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Entity File Number Entity File Number Debt Disclosure [Abstract] Expired (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Measurement Input Type [Domain] Measurement Input Type [Domain] Statement [Table] Statement [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Goodwill and intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Goodwill and Intangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Goodwill and Intangible Assets Preferred stock, shares issued Preferred Stock, Shares Issued Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Business Combinations [Abstract] Common stock, $0.0001 par value; 100,000,000 shares authorized; 19,821,716 and 4,519,533 shares issued at September 30, 2020 and December 31, 2019, and 19,818,912 and 4,511,174 shares outstanding at September 30, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Loss per common share - basic and diluted (usd per share) Earnings Per Share, Basic and Diluted Entity Small Business Entity Small Business Document Fiscal Year Focus Document Fiscal Year Focus Principles of Consolidation Consolidation, Policy [Policy Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Exercisable, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Number of shares issued Sale of Stock, Number of Shares Issued in Transaction Entity Current Reporting Status Entity Current Reporting Status Price per share (usd per share) Sale of Stock, Price Per Share PAYROLL PROTECTION PROGRAM Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Exercisable, weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Expected volatility Measurement Input, Price Volatility [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Amendment Flag Amendment Flag Loss Per Share Earnings Per Share, Policy [Policy Text Block] Equity-based compensation expense (shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Balance at December 31, 2019 Balance at September 30, 2020 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Nonemployee Share-based Payment Arrangement, Nonemployee [Member] Common stock, shares issued Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Shares remaining available for grant of stock awards (shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Cash payment to related party Repayments of Related Party Debt Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Issuance of equity securities for license Stock Issued During Period, Value, Issued for Services Current funding received Revenue From Grants, Current Funding Received Revenue From Grants, Funding Received During Period Entity Central Index Key Entity Central Index Key Related Party [Domain] Related Party [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Accounts Receivable Increase (Decrease) in Accounts Receivable Debt Instrument [Line Items] Debt Instrument [Line Items] Total stockholders' equity Equity, beginning balance Equity, ending balance Stockholders' Equity Attributable to Parent Offering costs Payments of Stock Issuance Costs Total purchase consideration Business Combination, Consideration Transferred Fair value of rights to warrants Business Combination, Consideration Transferred, Fair Value of Rights to Warrants Business Combination, Consideration Transferred, Fair Value of Rights to Warrants Total liabilities and stockholders' equity Liabilities and Equity Warrants Derivatives, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town SUBSEQUENT EVENTS Subsequent Events [Text Block] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Total fair value of liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities General and administrative General and Administrative Expense Change in fair value of warrant liability Change in fair value of warrant liability Change in Fair Value Fair Value Adjustment of Warrants Unrecognized compensation cost, options Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Antidilutive securities excluded from computation of earnings per share (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2015 Plan Equity Incentive Plan 2015 [Member] Equity Incentive Plan 2015 [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Net loss Business Acquisition, Pro Forma Net Income (Loss) Entity Ex Transition Period Entity Ex Transition Period Equity Component [Domain] Equity Component [Domain] Expected dividend Measurement Input, Expected Dividend Rate [Member] Effect of reverse acquisition Stock Issued During Period, Value, Acquisitions Grantee Status [Domain] Grantee Status [Domain] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Payment of dividend Payments of Dividends Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Property and equipment, net Property, Plant and Equipment, Net Entity Tax Identification Number Entity Tax Identification Number Prepaid insurance Prepaid Insurance Interest income (expense), net Interest Income (Expense), Nonoperating, Net Expected life (years) Warrants and Rights Outstanding, Term EQUITY-BASED COMPENSATION Share-based Payment Arrangement [Text Block] Net loss Net loss Net Income (Loss) Attributable to Parent Grants receivable Increase (Decrease) in Other Receivables Satisfy success fee Satisfy Success Fee Due to Related Party [Member] Satisfy Success Fee Due to Related Party Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Issuance of equity securities for license (shares) Stock Issued During Period, Shares, Issued for Services Other assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Issuance of equity securities Shares issued, value Stock Issued During Period, Value, New Issues Conversion of liabilities to equity Debt Conversion, Converted Instrument, Amount Grants receivable from CPRIT Receivables, Net, Current Loss from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Total assets Assets Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Current Fiscal Year End Date Current Fiscal Year End Date Operating expenses: Operating Expenses [Abstract] Warrant liability Derivative Liability, Current Title of 12(b) Security Title of 12(b) Security Government grants and other income Other Nonoperating Income Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Number of shares called by warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Financial Instruments and Credit Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Subsequent Events Subsequent Events, Policy [Policy Text Block] Period the right is unexercisable Class of Warrant or Right, Period Warrants or Rights Unexercisable Class of Warrant or Right, Period Warrants or Rights Unexercisable Depreciation, amortization and impairment Depreciation, Depletion and Amortization Ownership percentage by noncontrolling Owner Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Profit Interest Units Profit Interest Units [Member] Profit Interest Units Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Warrants exercised for cash Stock Issued During Period, Value, Warrants Exercised Stock Issued During Period, Value, Warrants Exercised Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Unrecognized compensation cost, recognition period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Warrants measurement input Warrants Outstanding, Measurement Input Warrants Outstanding, Measurement Input Flex Pharma Flex Pharma [Member] Flex Pharma Entity Filer Category Entity Filer Category Common Stock Common Stock [Member] Product and Service [Domain] Product and Service [Domain] Commitments and Contingencies Disclosure [Abstract] Due to related party Due to Related Parties Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Issuance of equity securities (shares) Shares issued Stock Issued During Period, Shares, New Issues Debt Instrument [Axis] Debt Instrument [Axis] Additional Paid-In Capital Additional Paid-in Capital [Member] Interest rate Debt Instrument, Interest Rate, Stated Percentage Summary of Purchase Consideration Schedule of Business Acquisitions, by Acquisition [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Preferred shares converted to common shares (shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Class A Common Class A [Member] Class of Stock [Line Items] Class of Stock [Line Items] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect REVERSE ACQUISITION AND DISPOSAL Business Combination Disclosure [Text Block] Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Common stock, shares outstanding Common Stock, Shares, Outstanding Employee stock option Share-based Payment Arrangement, Option [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] PREPAID EXPENSES AND OTHER CURRENT ASSETS Other Current Assets [Text Block] Issuance of shares for license Stock Issued Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Short-term Debt [Line Items] Short-term Debt [Line Items] Research and development Research and Development Expense Subsequent Events [Abstract] Subsequent Events [Abstract] Forfeited, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Ownership [Axis] Ownership [Axis] Grantee Status [Axis] Grantee Status [Axis] Weighted-average exercise price, Beginning Balance (in usd per share) Weighted-average exercise price, Ending Balance (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Sale of Stock [Domain] Sale of Stock [Domain] Note Payable Notes Payable to Banks [Member] Ownership [Domain] Ownership [Domain] Common stock, shares authorized Common Stock, Shares Authorized Voting interest acquired Business Acquisition, Percentage of Voting Interests Acquired Plan Name [Domain] Plan Name [Domain] Number of rights per share Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Matching funds requirement Revenue From Grants, Matching Funds Requirement Revenue From Grants, Matching Funds Requirement Grants Receivable and Revenue Recognition Revenue [Policy Text Block] Prepaid clinical trial expenses Prepaid Clinical Trial Expense Prepaid Clinical Trial Expense Impairment charges of long-lived assets Impairment of Long-Lived Assets Held-for-use ORGANIZATION AND OPERATIONS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Additional paid-in capital Additional Paid in Capital Castration-resistant prostate study Grant, Castration-Resistant Prostate Study [Member] Grant, Castration-Resistant Prostate Study Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Due to/from related party Increase (Decrease) in Due to Related Parties Proceeds received from disposal of discontinued operations Proceeds from Divestiture of Businesses Income Statement [Abstract] Income Statement [Abstract] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Over-Allotment Option Over-Allotment Option [Member] Local Phone Number Local Phone Number Schedule of Unaudited Pro Forma Results Business Acquisition, Pro Forma Information [Table Text Block] Flex Pharma market capitalization at closing Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Accrued Expenses And Other Current Liabilities Summary of Changes in Fair Value of Level 3 Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Current assets: Assets, Current [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Grant contract amount Contract with Customer, Liability Related Party Transaction [Domain] Related Party Transaction [Domain] Entity Emerging Growth Company Entity Emerging Growth Company Revenues Business Acquisition, Pro Forma Revenue Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Award Type [Axis] Award Type [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Legal Entity [Axis] Legal Entity [Axis] Common Units Common Units [Member] Common Units City Area Code City Area Code Maximum Maximum [Member] Proceeds from issuance of equity securities, net Proceeds from Other Equity Preferred stock, shares authorized Preferred Stock, Shares Authorized Document Period End Date Document Period End Date Accumulated Deficit Retained Earnings [Member] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Outstanding, weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Warrant value Warrants and Rights Outstanding Award Type [Domain] Award Type [Domain] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] University of Utah Research Foundation University of Utah Research Foundation [Member] University of Utah Research Foundation Accounts payable, accrued liabilities and other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Trading Symbol Trading Symbol Exercisable, weighted-average exercise price (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Aggregate amount received Revenue From Grants, Aggregate Amount Received Revenue From Grants, Aggregate Amount Received Note payable Notes Payable, Current Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Equity-based compensation expense Share-based Payment Arrangement, Noncash Expense Entity [Domain] Entity [Domain] Cover [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Current liabilities: Liabilities, Current [Abstract] Entity Shell Company Entity Shell Company Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Recurring Fair Value, Recurring [Member] Expired, weighted-average exercise price (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Application of New Accounting Standards and Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Discount rate Measurement Input, Discount Rate [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Loan Payable Loans Payable [Member] Continued payments, percent of net sales Revenue From Grants, Revenue-sharing Payments, Continued Payments, Percent of Net Sales Revenue From Grants, Revenue-sharing Payments, Continued Payments, Percent of Net Sales